Overview
Lornoxicam Versus Etodolac After Third Molar Surgery
Status:
Completed
Completed
Trial end date:
2022-09-29
2022-09-29
Target enrollment:
0
0
Participant gender:
All
All
Summary
Our study aimed to compare the effect of lornoxicam and etodolac on postoperative pain, edema and trismus following lower third molar extractionPhase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Kutahya Health Sciences UniversityTreatments:
Etodolac
Lornoxicam
Criteria
Inclusion Criteria:- Bilateral mesioangular impacted lower third molar
- Asymptomatic Third Molar (No history of infection)
- Systemically Healthy Person
- Person Between aged 18-30
Exclusion Criteria:
- People who are pregnant and lactation process
- People who had any systemic disease
- People who are gastrointestinal problems
- People who are sensitive to drugs used in study
- Lower Third Molar associated with cysts and infections